Enliven Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $22M | 1.1M | 20.47 |
| 2025-06-30 | $18M | 883k | 20.06 |
| 2025-03-31 | $16M | 819k | 19.68 |
| 2024-12-31 | $17M | 763k | 22.51 |
| 2024-09-30 | $19M | 750k | 25.55 |
| 2024-06-30 | $16M | 682k | 23.37 |
| 2024-03-31 | $8.4M | 476k | 17.59 |
| 2023-09-30 | $5.9M | 433k | 13.66 |
| 2023-06-30 | $8.5M | 414k | 20.41 |
| 2023-03-31 | $775k | 35k | 21.90 |